Crying in O.Y.

APR has crossed ₩1.5 trillion KRW (over $1B USD) in revenue — and is now expanding beyond skincare into professional-grade medical devices.

In this episode of Crying in O.Y., we break down why Medicube’s parent company is moving up the value chain, shifting from mass cosmetics into energy-based clinical equipment.

We cover:

• How APR doubled revenue year-over-year
• Why cosmetics margins eventually compress
• The economics of higher ASP through devices
• The clinic → home maintenance “treatment loop”
• The role of PDRN and longevity positioning
• What regulatory approval and hospital adoption will determine next

This isn’t product expansion. It’s margin expansion and category repositioning.

For professionals in beauty retail, brand strategy, distribution, and aesthetics.

South Korea’s retail landscape is undergoing a massive shift. In this episode, Zac explores the decline of traditional TV home shopping and the explosive growth of Live Commerce. We discuss the "Big Seven" networks, the crushing weight of transmission fees, and how platforms like Naver and Coupang are using "Rocket Delivery" and social engagement to capture the MZ generation. Plus, a look at how Live Commerce bridges the "Spatial Gap" for regional consumers and what the future holds for AI virtual hosts in the beauty space.

Follow the pod on IG: @cryingino.yLanguage & Global Insights: @goojeon.insight

Sorry for the late post—moving house is a full-time job! 📦 In today's episode, your host Zac explores the fascinating world of character collaborations in South Korea.

We’re moving beyond the surface-level "cuteness" to look at the hard data: Why do characters like MangGOM drive a 300%–400% increase in web traffic? We analyze the shift from children’s TV icons to "Kidult" culture and how brands like Beplain, Anua, and Numbuzin are using limited-edition merch to clear a quarter’s worth of inventory in just weeks.

Key Highlights:

• The business of "healing" through IP.

• Analysis of Olive Young’s ever-changing Best Seller list.

• How character branding helps K-beauty penetrate the US and SE Asian markets.

Stay Connected:IG: @cryinginoliveyoungK-Beauty Language Insights: @goojeon.insight

In this briefing, we dissect the emergence of K-Wellness via the launch of Olive Young's newest platform, Olive Better. We analyze the 2026 F.U.L.L.M.O.O.N. framework and why the industry is pivoting toward "Wholeness" and "Healthy Pleasure."

Professional Takeaways:

• Beyond Cosmetics: The strategic re-branding of "Health" to "Wellness" as a daily lifestyle practice.

• Longevity Economy: How the Gwanghwamun flagship targets high-stress corporate demographics.

• The Ingestible Wave: Data supporting the 140-fold increase in inner-beauty film and functional snack consumption.

Industry Network:

• Visuals: Follow @cryinginoliveyoung on Instagram for updates and more

• Global Market News: For insights into how K-Beauty globally, subscribe to @GooJeon—the definitive source for K-Beauty’s international market impact.

Host Zac returns to the "Crying in Olive Young" studio to dissect the success of Torriden, a brand that has mastered the middle ground between "Clean Beauty" and "Dermacosmetics."

With the Dive-In Low Molecular Hyaluronic Acid Serum reaching 11 million units sold as of 2025, Torriden isn't just a trend—it's a category leader. We explore the "5-D Complex" technology that makes their HA serum a global bestseller at Sephora and Boots, and why it consistently tops the Olive Young charts.

The Business Sidebar: We address the rumors surrounding LG Household & Health Care (LG H&H) and their interest in the indie market. What does CEO Lee Sun-Joo’s "Agile Adaptation" strategy mean for the future of K-Beauty? Plus, we provide an essential update on Dr. Althea’s recent press release regarding their 2026 expansion and internal sale discussions.

Key Highlights:

• Torriden’s "Your Skin is Our Planet" ethos.

• The math behind a 100-billion-won brand.

• Hyaluronic Acid: Molecular weights explained.

• LG H&H’s shift away from legacy brands toward indie prospects.

• Dr. Althea’s 2026 recruitment and growth update.

Connect with us:IG: @CryingInOliveYoungKorean Language K-Beauty Updates: @Goojeon

Episode Summary:Is Dr. Althea the next $450 million acquisition in K-beauty? In today’s episode, we step away from the hype to look at the cold, hard data behind one of 2026’s most successful skincare brands.

Host Zac breaks down the operational maturity of Dr. Althea—a brand that has moved 15 million units of its hero product, the 345 Relief Cream, while maintaining a lean, high-utility SKU strategy. We explore how the brand navigated a massive 1,300-door rollout into Ulta Beauty and why their focus on "skinimalism" and barrier health has made them a prime target for beauty conglomerates looking to bolster their portfolios.

Key Discussion Points:

• The Hybrid Advantage: How Dr. Althea bridges the gap between topical treatment and daily cosmetic use.

• Demographic Crossover: Why one product is winning with both Gen Z acne-care and Millennial longevity goals.

• Institutional Interest: Comparing Dr. Althea’s current trajectory to the landmark Dr. G acquisition of 2025.

Whether you're a skincare enthusiast or interested in the business of beauty, this episode provides a deep dive into the logistics and strategy of a brand at its peak.

The K-Beauty industry is entering its "Golden Era," but the landscape is shifting faster than ever. In the debut episode of Crying in Olive Young, your host Zac breaks down the heavy-hitting business news that industry professionals and hardcore K-Beauty fans need to know. We’re moving past the "viral product" hype to look at the numbers, export trends, and the massive corporate power shifts defining 2026.In this video, we analyze the groundbreaking Olive Young x Sephora partnership that is bringing curated K-beauty zones to 700+ stores globally. We also dive into the Goodai Global (Beauty of Joseon) IPO valuation of $6.8 billion and why the US has officially overtaken China as the #1 export market for Korean cosmetics.Key Topics Covered:The Tech Shift: Why "Bioactives," PDRN, and Spicule technology are replacing clinic-based dermatology treatments with at-home solutions.The Male Grooming Boom: Why 50% of Korean men aged 18-24 are using makeup and the $4.1B shaving market.Market Shifts: The rise of "Guochao" in China and how K-Beauty is pivoting to Poland, the UAE, and the "Silver Market" (Pro-aging).IPO Watch: Financial breakdowns for Goodai Global, Benow (Numbuzin/Fwee), and Seorin Company (Round Lab).Stay ahead of the curve in the $13.24 Billion K-Beauty market. Subscribe for weekly industry wrap-ups, data-driven insights, and behind-the-scenes analysis from the heart of Seoul.Follow Zac on Instagram:https://www.instagram.com/cryinginoliveyoung?igsh=MWVvOXBnZDAwOW5yMg==